Skip to main content

LWCN Strategy Board

The LWCN Strategy Board maintains strategic oversight of Lymphoedema Wales Clinical Network (LWCN) and considers, scrutinises and agrees recommendations made by the LWCN Programme Board providing assurance and endorsement to the All Wales NHS Chief Executives Forum.  The LWCN Strategy Board provides the source of composite advice to Welsh Government, Chief Executive Officers and Health Boards as required and informs Welsh Government of the progress towards benefit realisation of the programme.  The Board meets bi-annually and is chaired by a Chief Executive of one of the seven Welsh Health Boards.

The current chair of the LWCN Strategy Board is Nicola Prygodzicz, Chief Executive, Aneurin Bevan University Health Board and includes the following representation:

Clinical Director, LWCN

National Lymphoedema Education & Research Lead, LWCN

Programme Management Office Representation, LWCN

Chair LWCN Programme Board

Health of Older People’s Health & Chronic Conditions Management, Welsh Government

Director of Therapies and Health Sciences, SBUHB

Director of Improvement & Innovation, CTMUHB

Director Clinical Strategy, PTHB

Director of Transformation, BCUHB

Director of Nursing, CVUHB

Director Primary and Community Care, ABUHB

Associate Medical Director Transformation and Value Based Health Care, HDUHB

Chief Pharmacy, Velindre

Deputy Director of Finance, Velindre

Director of Digital Strategy, Digital Health and Care Wales

Academic Representative

Health Care Inspectorate Wales Representative

Patient Representatives

Assistant Director Finance, Finance Delivery Unit